Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 100858-33-1 Chemical Structure| 100858-33-1
Chemical Structure| 100858-33-1
Product Citations

Alternative Products

Product Details of [ 100858-33-1 ]

CAS No. :100858-33-1
Formula : C12H15NO3
M.W : 221.25
SMILES Code : O=C(N1C[C@H](O)CC1)OCC2=CC=CC=C2
MDL No. :MFCD07368258
InChI Key :MBLJFGOKYTZKMH-LLVKDONJSA-N
Pubchem ID :11183628

Safety of [ 100858-33-1 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H319-H335
Precautionary Statements:P261-P301+P310-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Calculated chemistry of [ 100858-33-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 16
Num. arom. heavy atoms 6
Fraction Csp3 0.42
Num. rotatable bonds 4
Num. H-bond acceptors 3.0
Num. H-bond donors 1.0
Molar Refractivity 62.98
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

49.77 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.35
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.13
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.86
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.14
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.13
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.32

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.94
Solubility 2.56 mg/ml ; 0.0116 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.77
Solubility 3.77 mg/ml ; 0.017 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.14
Solubility 1.61 mg/ml ; 0.00726 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.85 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.63

Application In Synthesis [ 100858-33-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 100858-33-1 ]

[ 100858-33-1 ] Synthesis Path-Downstream   1~7

  • 1
  • [ 31970-04-4 ]
  • [ 100858-32-0 ]
  • [ 100858-33-1 ]
  • 2
  • [ 100858-33-1 ]
  • [ 100858-32-0 ]
YieldReaction ConditionsOperation in experiment
89% Sodium trifluoroacetate (32.6 g) was suspended in toluene (213 g), and DFI (32.6 g) was added dropwise thereto at 0C. The mixture was stirred at 0C for 1 hour, and then R-CHP (44.2 g) was added thereto. The reaction solution was stirred at 0C for 1 hour, and then at 50C for 2 hours. The reaction solution was kept at 15C or lower, a 5 wt% aqueous sodium hydrogen carbonate solution (480 g) was added dropwise to the reaction solution, which was stirred at room temperature for 30 min. Subsequently, the toluene layer was separated. The toluene layer was washed three times with water (100 g), and then concentrated under reduced pressure. To the obtained residue were added toluene (40 g) and hexane (80 g), and the mixture was crystallized at 0C. The obtained crystal was collected by filtration, and dried at 40C for 12 hours under reduced pressure to obtain a target compound. Amount 39.3 g Yield 89% Stereoisomer ratio S-CHP:R-CHP=99.9:0.1 1H-NMR (toluene-d8, 400 MHz) delta 7.23-7.20 (m, 2H), 7.13-6.98 (m, 3H), 5.11-4.99 (m, 2H), 3.93 (bs, 1H), 3.46-3.12 (m, 4H), 1.65-1.45 (m, 1H), 1,45-1.30 (m, 1H) The stereoselectivity in the reaction was determined by using the concentrated residue before crystallization and using the peak area ratio of S-CHP and R-CHP under an HPLC analysis condition 6. S-CHP:R-CHP=99.8:0.2
85% Sodium trifluoroacetate (2.04 g) was suspended in toluene (10 g), and PPDA (3.35 g) was added dropwise thereto at 0C. The mixture was stirred at 0C for 1 hour, and then R-CHP (1.11 g) was added thereto. The reaction solution was stirred at 0C for 1 hour, and then at 50C for 2 hours. To the reaction solution was added toluene (20 g), and the mixture was kept at 15C or lower, and added dropwise to an ice-cooled, 5 wt% aqueous sodium hydrogen carbonate solution (30 g). The reaction solution was stirred at room temperature for 30 min, and then the toluene layer was separated. The toluene layer was washed three times with water (20 g), and then concentrated under reduced pressure to obtain a residue as a pale brown solid containing a target compound. Amount 0.94 g Yield 85% The stereoselectivity in this reaction was determined from the peak area ratio of S-CHP and R-CHP under an HPLC analysis condition-6. Stereoisomer ratio S-CHP:R-CHP=96:4 1H-NMR (toluene-d8, 400 MHz) was consistent with that in Example 29.
78% Sodium trifluoroacetate (2.04 g) was suspended in toluene (10 g), and BDDF (2.07 g) was added dropwise thereto at 0C. The mixture was stirred at 0C for 1 hour, and then R-CHP (1.11 g) was added thereto. The reaction solution was stirred at 0C for 1 hour, and then at 50C for 2 hours. To the reaction solution was added toluene (20 g), and the mixture was kept at 15C or lower, and added dropwise to an ice-cooled, 5 wt% aqueous sodium hydrogen carbonate solution (30 g). The reaction solution was stirred at room temperature for 30 min, and then the toluene layer was separated. The toluene layer was washed three times with water (20 g), and then concentrated under reduced pressure to obtain a residue as a pale brown solid containing a target compound. Amount 0.87 g Yield 78% The stereoselectivity in this reaction was determined from the peak area ratio of S-CHP and R-CHP under an HPLC analysis condition-6. Stereoisomer ratio S-CHP:R-CHP=94:6 1H-NMR (toluene-d8, 400 MHz) was consistent with that in Example 29.
  • 4
  • [ 501-53-1 ]
  • [ 122536-94-1 ]
  • [ 100858-32-0 ]
  • [ 100858-33-1 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In water; a) Preparation of benzyl (S)-3-hydroxy-pyrrolidine-1-carboxylate The pH of a solution of 6.18 g of (S)-3-hydroxy-pyrrolidine hydrochloride in 175 ml of water was adjusted to 10 with 10% sodium hydroxide solution and cooled to 0-5 C. 7.1 ml of benzyl chloroformate were added dropwise within 30 minutes under argon, with the pH of the solution being held between 9.5 and 11.5 by the dropwise addition of 10% sodium hydroxide solution. After completion of the addition the suspension was stirred at room temperature for 16 hours. The suspension was extracted with ethyl acetate, the organic phase was washed with water, dried over Na2 SO4, filtered and the filtrate was concentrated. Purification of the crude product over a silica gel column gave 7.33 g of benzyl (R)-3-hydroxy-pyrrolidine-1-carboxylate as a beige liquid.
  • 5
  • [ 25070-74-0 ]
  • [ 100858-32-0 ]
  • [ 100858-33-1 ]
  • 6
  • [ 108-22-5 ]
  • [ 95656-88-5 ]
  • (R)-benzyl 3-acetoxypyrrolidine-1-carboxylate [ No CAS ]
  • [ 100858-32-0 ]
  • [ 100858-33-1 ]
  • 7
  • [ 95656-88-5 ]
  • [ 100858-32-0 ]
  • [ 100858-33-1 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 100858-33-1 ]

Aryls

Chemical Structure| 95656-88-5

A119384 [95656-88-5]

Benzyl 3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-32-0

A145605 [100858-32-0]

Benzyl (S)-3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-34-2

A119916 [100858-34-2]

(R)-Benzyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 95798-22-4

A351272 [95798-22-4]

Benzyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 648418-25-1

A284599 [648418-25-1]

Benzyl 4-hydroxyazepane-1-carboxylate

Similarity: 0.90

Alcohols

Chemical Structure| 95656-88-5

A119384 [95656-88-5]

Benzyl 3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-32-0

A145605 [100858-32-0]

Benzyl (S)-3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-34-2

A119916 [100858-34-2]

(R)-Benzyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 95798-22-4

A351272 [95798-22-4]

Benzyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 648418-25-1

A284599 [648418-25-1]

Benzyl 4-hydroxyazepane-1-carboxylate

Similarity: 0.90

Amides

Chemical Structure| 95656-88-5

A119384 [95656-88-5]

Benzyl 3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-32-0

A145605 [100858-32-0]

Benzyl (S)-3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-34-2

A119916 [100858-34-2]

(R)-Benzyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 95798-22-4

A351272 [95798-22-4]

Benzyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 648418-25-1

A284599 [648418-25-1]

Benzyl 4-hydroxyazepane-1-carboxylate

Similarity: 0.90

Related Parent Nucleus of
[ 100858-33-1 ]

Pyrrolidines

Chemical Structure| 95656-88-5

A119384 [95656-88-5]

Benzyl 3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 100858-32-0

A145605 [100858-32-0]

Benzyl (S)-3-hydroxypyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 72597-18-3

A294479 [72597-18-3]

(R)-Benzyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate

Similarity: 0.86

Chemical Structure| 1217619-19-6

A137097 [1217619-19-6]

(S)-Benzyl 3-(aminomethyl)pyrrolidine-1-carboxylate hydrochloride

Similarity: 0.84

Chemical Structure| 1217726-65-2

A247896 [1217726-65-2]

(R)-Benzyl 3-(aminomethyl)pyrrolidine-1-carboxylate hydrochloride

Similarity: 0.84